Effects of estradiol and estradiol sulfamate on the liver of ovariectomized or ovariectomized and hypophysectomized rats

Journal of Steroid Biochemistry and Molecular Biology

Volumn 80, Issue 4-5, 2002, Pages 457-467

  Sahlin, Lena ^a   Elger, Walter ^b   Hedden, Annemarie ^b   Lindberg, Monica ^a   Reddersen, Gudrun ^b   Schneider, Birgitt ^b   Schwarz, Sigfrid ^c   Freyschuss, Bo ^a,d   Eriksson, Håkan ^a  

^a Department of Woman and Child Health   (Sweden)

^b EnTec GmbH   (Germany)

^c BAYER PHARMA AG   (Germany)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

Angiotensin; Cholesterol; Estrogen receptor; HDL; Liver; Triglycerides

Indexed keywords

ANGIOTENSIN I; DEXAMETHASONE; ESTRADIOL; ESTRADIOL DERIVATIVE; ESTRADIOL SULFAMATE; ESTROGEN RECEPTOR; GROWTH HORMONE; HIGH DENSITY LIPOPROTEIN; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; J 995; MESSENGER RNA; TRIACYLGLYCEROL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BINDING ASSAY; CONTROLLED STUDY; DRUG EFFECT; DRUG EFFICACY; ENZYME IMMUNOASSAY; FEMALE; HYPOPHYSECTOMY; LIGAND BINDING; LIVER LEVEL; NONHUMAN; OVARIECTOMY; RAT; RNA HYBRIDIZATION;

EID: 0036238637     PISSN: 09600760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0960-0760(02)00031-6     Document Type: Article

References (44)

1. A comparison of serum oestrogen levels after percutaneous and oral administration of 17β-estradiol
2. Regulation of estrogen receptor concentration in target organs of the rat
3. Effects of percutaneous estradiol and conjugated estrogens on the level of plasma proteins and triglycerides in postmenopausal women
4. Percutaneous estrogen therapy: Endometrial response and metabolic effects
5. Differential metabolic tolerance between oral and percutaneous administration of estradiol in postmenopausal women
6. Efficacy of transdermal estradiol
7. Sulfamates of various estrogens are prodrugs with increased systemic and reduced hepatic estrogenicity at oral application
8. Studies on the transhepatic transfer of estradiol sulfamate J 995 (ES) and the mechanism of systemic release of estradiol
9. Blood, tissue, and bone concentration of estradiol (E) and estradiol sulfamate (ES) and their elimination after oral administration
10. Novel oestrogen sulfamates: A new approach to oral hormone therapy
11. Influence of subchronic administration of oestradiol, ethinyloestradiol and oestradiol sulphamate on bile flow, bile acid excretion, and liver and biliary glutathione status in rats
12. Effects of estradiol and estradiol sulfamate on the uterus of ovariectomized or ovariectomized and hypophysectomized rats
13. The hormonal regulation of the estrogen receptor in rat liver: An interplay involving growth hormone, thyroid hormones and glucocorticoids
14. Androgen regulation of the insulin-like growth factor-I and the estrogen receptor in rat uterus and liver
15. A practical approach for quantitating specific mRNA by solution hybridization
16. A simple, rapid, and sensitive DNA assay procedure
17. Dexametasone attenuates the estradiol-induced increase of IGF-I mRNA in the rat uterus
18. Efficient in vitro synthesis of biologically active RNA and RNA hybridization probes from plasmids containing bacteriophage SP6 promoter
19. Regulation of insulin-like growth factor-I gene expression by growth hormone
20. Oestrogen receptor mRNA and a related RNA transcript in mouse ovaries
21. Structural organization and expression of the mouse estrogen receptor
22. Regulatory effects of growth hormone, glucocorticoids, and thyroid hormone on the estrogen receptor level in the rat liver
23. Induction of estrogen receptors by growth hormone and glucocorticoid substitution in primary cultures of rat hepatocytes
24. Relation of the adrenal and pituitary to the hypocholesterolemic effect of estrogens in rats
25. Multihormonal regulation of the estrogen receptor in rat liver
26. Correlation of estrogen receptor concentrations and estrogen-mediated elevation of very low-density lipoproteins
27. Hormones and liver function
28. Steroids and lipid metabolism: Mechanisms of action
29. Changes in plasma lipoprotein and apoprotein composition in relation to oral versus percutaneous administration of estrogen alone or in cyclic association with utrogestan in menopausal women
30. High-density lipoprotein 2 and hepatic lipase: Reciprocal changes produced by estrogen and norgestrel
31. Estrogen therapy and liver function: Metabolic effects of oral and parenteral administration
32. Effects of hormone replacement therapy
33. Role of the liver for receptor-mediated catabolism of low-density lipoprotein in the 17α-ethinylestradiol treated rat
34. Risks of estrogens and progestogens
35. Oestrogens and atherosclerotic vascular disease - Local vascular factors
36. On the regulation of sex-hormone binding globulin: A challenge of an old dogma and outlines of an alternative mechanism
37. Potency of different oestrogen preparations
38. Comparative endocrinological and clinical effects of percutaneous estradiol and oral conjugated estrogens as replacement therapy in menopausal women
39. Regulation of hepatic angiotensinogen synthesis and secretion by steroid hormones
40. Estrogenic influence on the regulation of the hepatic estrogen receptor α and the plasma level of angiotensinogen in female rats
41. Studies on angiotensinogen formation in a liver perfusion system
42. Effects of oestrogen and human growth hormone on pregnancy-associated plasma proteins in the rat
43. Glucocorticoid- and estrogen-responsive elements in the 5′-flanking region of the rat angiotensinogen gene
44. Angiotensinogen synthesis in the liver is independent of physiological estrogen levels